section icon

Combining structural biology, immunology, and protein biophysics, Structured Immunity's platform technology is capable of more rapidly and predictively validating and optimizing lead T cell receptor candidates for improved immunotherapy.

We are actively developing partnerships with leading biopharmaceutical companies interested in leveraging our platform's capabilities.